Christopher has been a neuroscientist, day trader, and cofounder of an adtech startup in Chicago. He is currently the Managing Partner of Pallasite Ventures, an early- stage venture fund with a growing portfolio of more than 55 companies across Canada and the US. Pallasite is currently investing in later seed-stage medtech companies tackling challenging health issues, from Parkinson’s disease to genetic engineering, while also working on software to empower patents and drive access to medical services. Pallasite is also actively investing in fintech and business optimization SaaS companies. Chris devotes a significant amount of time to mentoring founders to support the startup tech ecosystem.